AAAAAA

   
Results: 1-9 |
Results: 9
Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy
Authors: Kucuk, O Sarkar, FH Sakr, W Djuric, Z Pollak, MN Khachik, F Li, YW Banerjee, M Grignon, D Bertram, JS Crissman, JD Pontes, EJ Wood, DP
Citation: O. Kucuk et al., Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy, CANC EPID B, 10(8), 2001, pp. 861-868
Serum insulin-like growth factor-I (IGF-I) does not correlate positively with isometric strength, fatigue, and quality of life in post-polio syndrome
Authors: Trojan, DA Collet, JP Pollak, MN Shapiro, S Jubelt, B Miller, RG Agre, JC Munsat, TL Hollander, D Tandan, R Robinson, A Finch, L Ducruet, T Cashman, NR
Citation: Da. Trojan et al., Serum insulin-like growth factor-I (IGF-I) does not correlate positively with isometric strength, fatigue, and quality of life in post-polio syndrome, J NEUR SCI, 182(2), 2001, pp. 107-115
Critical evaluation of the safety of recombinant human growth hormone administration: Statement from the growth hormone research society
Authors: Christiansen, JS Bengtsson, BA Thorner, MO Hintz, R Sonksen, PH Cohen, P Clemmons, D Strasburger, CJ Carlsson, L Tanaka, T Robinson, I Jorgensen, JO Johannson, G Clayton, PE Cowell, CT Malozowski, SN Hankinson, S Yee, D Baxter, R Swerdlow, A Rosenfeld, R Fradkin, JE Nishi, Y Monson, JP van den Berghe, G Carroll, PV Takala, J van der Lely, AJ Pollak, MN LeRoith, D Tachibana, K Kappelgaard, AM Langbakke, I Lippe, B Wilton, P Stein, P Salazar, DE Maneatis, T Blethen, SL Cutler, GB Blum, WF Svanberg, E Gertner, JM Shimatsu, A Takahashi, H
Citation: Js. Christiansen et al., Critical evaluation of the safety of recombinant human growth hormone administration: Statement from the growth hormone research society, J CLIN END, 86(5), 2001, pp. 1868-1870
A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women
Authors: Giovannucci, E Pollak, MN Platz, EA Willett, WC Stampfer, MJ Majeed, N Colditz, GA Speizer, FE Hankinson, SE
Citation: E. Giovannucci et al., A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women, CANC EPID B, 9(4), 2000, pp. 345-349
Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome
Authors: Foulkes, WD Chappuis, PO Wong, N Brunet, JS Vesprini, D Rozen, F Yuan, ZQ Pollak, MN Kuperstein, G Narod, SA Begin, LR
Citation: Wd. Foulkes et al., Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome, ANN ONCOL, 11(3), 2000, pp. 307-313
Vertex balding, plasma insulin-like growth factor 1, and insulin-like growth factor binding protein 3
Authors: Platz, EA Pollak, MN Willett, WC Giovannucci, E
Citation: Ea. Platz et al., Vertex balding, plasma insulin-like growth factor 1, and insulin-like growth factor binding protein 3, J AM ACAD D, 42(6), 2000, pp. 1003-1007
Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3
Authors: Ma, J Pollak, MN Giovannucci, E Chan, JM Tao, YZ Hennekens, CH Stampfer, MJ
Citation: J. Ma et al., Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3, J NAT CANC, 91(7), 1999, pp. 620-625
Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men
Authors: Platz, EA Pollak, MN Rimm, EB Majeed, N Tao, YZ Willett, WC Giovannucci, E
Citation: Ea. Platz et al., Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men, CANC EPID B, 8(12), 1999, pp. 1107-1110
A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma
Authors: Ingle, JN Suman, VJ Kardinal, CG Krook, JE Mailliard, JA Veeder, MH Loprinzi, CL Dalton, RJ Hartmann, LC Conover, CA Pollak, MN
Citation: Jn. Ingle et al., A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma, CANCER, 85(6), 1999, pp. 1284-1292
Risultati: 1-9 |